AI Terminal
CVS GROUP PLC
Director's Dealing • Sep 23, 2022
7590_dirs_2022-09-23_2cf91ff5-4b06-4447-839f-c3e17464a1d4.html
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 3782A
CVS Group plc
23 September 2022
23 September 2022
CVS Group plc
("CVS" or the "Company")
PDMR Dealings
CVS, one of the UK's leading providers of integrated veterinary services, announces that it was notified on 22 September 2022 that Richard Connell, Non-executive Chairman of the Company and his wife purchased a total of 4,500 ordinary shares of 0.2p each in the Company ("Ordinary Shares") on the same date.
As a result, Mr Connell's total interest in the Company, including his wife's holdings, is now 169,000 Ordinary Shares, representing 0.24% per cent of the total voting rights of the Company. The notification below, made in accordance with the requirements of UK MAR, provides further detail.
| Contacts: CVS Group plc Jenny Farrer Company Secretary |
via MHP Communications |
| Peel Hunt (Nominated Adviser & Broker) Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose |
+44 (0)20 7418 8900 |
| MHP Communications (Financial PR) Andrew Jaques / Simon Hockridge / Rachel Farrington / Charles Hirst |
+44 (0) 20 3128 8549 |
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Richard Connell via James Hay Pension Trustees Limited
2
Reason for the notification
a)
Position/status
PDMR (Chairman) / PCA
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
CVS Group plc
b)
LEI
213800J41XDQ2NX48O05
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 0.2 pence each
GB00B2863827
b)
Nature of the transaction
On-market purchase
c)
Price(s) and volume(s)
| Price(s) - pence | Volume(s) |
| 16.18 | 1,000 |
d)
Aggregated information
- Aggregated volume
- Price
1,000
1,618.00
e)
Date of the transaction
22 September 2022
f)
Place of the transaction
London Stock Exchange - AIM (XLON)
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Richard Connell and Maire Elizabeth Connell
2
Reason for the notification
a)
Position/status
PDMR (Chairman) / PCA of a Director
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
CVS Group plc
b)
LEI
213800J41XDQ2NX48O05
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 0.2 pence each
GB00B2863827
b)
Nature of the transaction
On-market purchase
c)
Price(s) and volume(s)
| Price(s) - pence | Volume(s) |
| 16.18 | 3,500 |
d)
Aggregated information
- Aggregated volume
- Price
3,500
1,618.00
e)
Date of the transaction
22 September 2022
f)
Place of the transaction
London Stock Exchange - AIM (XLON)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHEANNAAFAAEFA